To elucidate the mechanism by which MH modulates the cellular components of the TME and exerts the observed anti-tumor response, RNA was extracted from purified, intratumoral, CD45+ cells, or whole tumor tissue, of SC-treated or MH-treated mice. This evidence concerns the gene PTPRC and neoplasm.